Evidence for a Pathogenic Determinant in HIV-1 Nef Involved in B Cell Dysfunction in HIV/AIDS

Cell Host and Microbe

Volumn 4, Issue 1, 2008, Pages 63-76

  Swingler, Simon ^a   Zhou, Jin ^a   Swingler, Catherine ^a   Dauphin, Ann ^a   Greenough, Thomas ^a   Jolicoeur, Paul ^b   Stevenson, Mario ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

CELLIMMUNO; MICROBIO; MOLIMMUNO

Indexed keywords

ACUTE PHASE PROTEIN; FERRITIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEF PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FERRITIN BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HYPERGAMMAGLOBULINEMIA; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TRANSGENIC MOUSE; VIRUS LOAD;

ANIMALS; B-LYMPHOCYTES; FERRITINS; HIV-1; HUMANS; HYPERGAMMAGLOBULINEMIA; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, TRANSGENIC; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; NF-KAPPA B; STATISTICS AS TOPIC; VIRAL LOAD; VIRULENCE FACTORS;

HUMAN IMMUNODEFICIENCY VIRUS 1; MUS MUSCULUS;

EID: 46949095793     PISSN: 19313128     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chom.2008.05.015     Document Type: Article

References (47)

1. Abelian A., Burling K., Easterbrook P., and Winter G. Hyperimmunoglobulinemia and rate of HIV type 1 infection progression. AIDS Res. Hum. Retroviruses 20 (2004) 127-128
2. Amadori A., Zamarchi R., Ciminale V., Del Mistro A., Siervo S., Alberti A., Colombatti M., and Chieco-Bianchi L. HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection. J. Immunol. 143 (1989) 2146-2152
3. Anderson G., Faulk W., Arosio P., Moss D., Powell L., and Halliday J. Identification of H- and L-ferritin subunit binding sites on human T and B lymphoid cells. Br. J. Haematol. 73 (1989) 260-264
4. Ben-Arieh S.V., Zimerman B., Smorodinsky N.I., Yaacubovicz M., Schechter C., Bacik I., Gibbs J., Bennink J.R., Yewdell J.W., Coligan J.E., et al. Human cytomegalovirus protein US2 interferes with the expression of human HFE, a nonclassical class I major histocompatibility complex molecule that regulates iron homeostasis. J. Virol. 75 (2001) 10557-10562
5. Boom J., Kosters E., Duncombe C., Kerr S., Hirschel B., Ruxrungtham K., de Mast Q., Kosalaraksa P., Ulbolyam S., Jupimai T., and Ananworanich J. Ferritin levels during structured treatment interruption of highly active antiretroviral therapy. HIV Med. 8 (2007) 388-395
6. Brown K., Gerstberger S., Carlson L., Franzoso G., and Siebenlist U. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267 (1995) 1485-1488
7. Butte A., Ye J., Häring H., Stumvoll M., White M., and Kohane I.S. Determining significant fold differences in gene expression analysis. Pac. Symp. Biocomput. (2001) 6-17
8. Conge A.M., Tarte K., Reynes J., Segondy M., Gerfaux J., Zembala M., and Vendrell J.P. Impairment of B-lymphocyte differentiation induced by dual triggering of the B-cell antigen receptor and CD40 in advanced HIV-1-disease. AIDS 12 (1998) 1437-1449
9. Cozzi A., Corsi B., Levi S., Santambrogio P., Biasiotto G., and Arosio P. Analysis of the biologic functions of H- and L-ferritins in HeLa cells by transfection with siRNAs and cDNAs: evidence for a proliferative role of L-ferritin. Blood 103 (2004) 2377-2383
10. De Milito A. B lymphocyte dysfunctions in HIV infection. Curr. HIV Res. 2 (2004) 11-21
11. De Milito A., Nilsson A., Titanji K., Thorstensson R., Reizenstein E., Narita M., Grutzmeier S., Sonnerborg A., and Chiodi F. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 103 (2004) 2180-2186
12. Drakesmith H., Chen N., Ledermann H., Screaton G., Townsend A., and Xu X.N. HIV-1 Nef down-regulates the hemochromatosis protein HFE, manipulating cellular iron homeostasis. Proc. Natl. Acad. Sci. USA 102 (2005) 11017-11022
13. Embretson J., Zupancic M., Ribas J.L., Burke A., Racz P., Tenner-Racz K., and Haase A.T. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362 (1993) 359-362
14. Eriksson K., Kilander A., Hagberg L., Norkrans G., Holmgren J., and Czerkinsky C. Virus-specific antibody production and polyclonal B-cell activation in the intestinal mucosa of HIV-infected individuals. AIDS 9 (1995) 695-700
15. Fahmy M., and Young S.P. Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: changes in transferrin uptake, iron handling and ferritin mRNA. Biochem. J. 296 (1993) 175-181
16. Fargion S., Fracanzani A.L., Brando B., Arosio P., Levi S., and Fiorelli G. Specific binding sites for H-ferritin on human lymphocytes: modulation during cellular proliferation and potential implication in cell growth control. Blood 78 (1991) 1056-1061
17. Fauci A.S. Multifactorial nature of human immunodeficiency virus disease: Implications for therapy. Science 262 (1993) 1011-1018
18. Fenard D., Yonemoto W., de Noronha C., Cavrois M., Williams S.A., and Greene W.C. Nef is physically recruited into the immunological synapse and potentiates T cell activation early after TCR engagement. J. Immunol. 175 (2005) 6050-6057
19. Gendelman H.E., Orenstein J.M., Martin M.A., Ferruca C., Mitra R., Phipps T., Wahl L.A., Lane H.C., Fauci A.S., and Burke D.S. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J. Exp. Med. 167 (1988) 1428-1441
20. Gordeuk V., Delanghe J., Langlois M., and Boelaert J. Iron status and the outcome of HIV infection: an overview. J. Clin. Virol. 20 (2001) 111-115
21. Guilherme A., Emoto M., Buxton J., Bose S., Sabini R., Theurkauf W., Leszyk J., and Czech M. Perinuclear localization and insulin responsiveness of GLUT4 requires cytoskeletal integrity in 3T3-L1 adipocytes. J. Biol. Chem. 8 (2000) 38151-38159
22. Hanna Z., Kay D.G., Rebai N., Guimond A., Jothy S., and Jolicoeur P. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95 (1998) 163-175
23. Iimuro Y., Nishiura T., Hellerbrand C., Behrns K.E., Schoonhoven R., Grisham J.W., and Brenner D.A. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J. Clin. Invest. 101 (1998) 802-811
24. Jacobson D.L., McCutchan J.A., Spechko P.L., Abramson I., Smith R.S., Bartok A., Boss G.R., Durand D., Bozzette S.A., Spector S.A., et al. The evolution of lymphadenopathy and hypergammaglobulinemia are evidence for early and sustained polyclonal B lymphocyte activation during human immunodeficiency virus infection. J. Infect. Dis. 163 (1991) 240-246
25. Jego G., Robillard N., Puthier D., Amiot M., Accard F., Pineau D., Harousseau J.L., Bataille R., and Pellat-Deceunynck C. Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells. Blood 94 (1999) 701-712
26. Kacani L., Stoiber H., and Dierich M.P. Role of IL-15 in HIV-1-associated hypergammaglobulinaemia. Clin. Exp. Immunol. 108 (1997) 14-18
27. Kikyo N., Hagiwara K., Yazaki Y., and Okabe T. Growth stimulation of ferritin of human leukemia cells in vitro. J. Cancer Res. Clin. Oncol. 121 (1995) 76-78
28. Lane H.C., Masur H., Edgar L.C., Whalen G., Rook A.H., and Fauci A.S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 309 (1983) 453-458
29. Li R., Luo C., Mines M., Zhang J., and Fan G.H. Chemokine CXCL12 induces binding of ferritin heavy chain to the chemokine receptor CXCR4, alters CXCR4 signaling, and induces phosphorylation and nuclear translocation of ferritin heavy chain. J. Biol. Chem. 281 (2006) 37616-37627
30. Lucey D.R., Hendrix C.W., Andrzejewski C., Melcher G.P., Butzin C.A., Henry R., Wians Jr. F.H., and Boswell R.N. Comparison by race of total serum IgG, IgA, and IgM with CD4+ T-cell counts in North American persons infected with the human immunodeficiency virus type 1. J. Acquir. Immune Defic. Syndr. 5 (1992) 325-332
31. Mangino G., Percario Z.A., Fiorucci G., Vaccari G., Manrique S., Romeo G., Federico M., Geyer M., and Affabris E. In vitro treatment of human monocytes/macrophages with myristoylated recombinant Nef of human immunodeficiency virus type 1 leads to the activation of mitogen-activated protein kinases, IkappaB kinases, and interferon regulatory factor 3 and to the release of beta interferon. J. Virol. 81 (2007) 2777-2791
32. Martinez-Maza O., Crabb E., Mitsuyasu R.T., Fahey J.L., and Giorgi J.V. Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. J. Immunol. 138 (1987) 3720-3724
33. Moir S., Malaspina A., Ogwaro K.M., Donoghue E.T., Hallahan C.W., Ehler L.A., Liu S., Adelsberger J., Lapointe R., Hwu P., et al. HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc. Natl. Acad. Sci. USA 98 (2001) 10362-10367
34. Muller F., Aukrust P., Nordoy I., and Froland S.S. Possible role of interleukin-10 (IL-10) and CD40 ligand expression in the pathogenesis of hypergammaglobulinemia in human immunodeficiency virus infection: modulation of IL-10 and Ig production after intravenous Ig infusion. Blood 92 (1998) 3721-3729
35. Niiro H., and Clark E. Regulation of B-cell fate by antigen-receptor signals. Nat. Rev. Immunol. 2 (2002) 945-956
36. Olive A., and Junca J. Elevated serum ferritin levels: associated diseases and clinical significance. Am. J. Med. 101 (1996) 120-122
37. Olivetta E., Percario Z., Fiorucci G., Mattia G., Schiavoni I., Dennis C., Jager J., Harris M., Romeo G., Affabris E., and Federico M. HIV-1 Nef induces the release of inflammatory factors from human monocyte/macrophages: involvement of Nef endocytotic signals and NF-kappa B activation. J. Immunol. 170 (2003) 1716-1727
38. Pahwa S., Pahwa R., Good R.A., Gallo R.C., and Saxinger C. Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes. Proc. Natl. Acad. Sci. USA 83 (1986) 9124-9128
39. Patke C.L., and Shearer W.T. gp120- and TNF-alpha-induced modulation of human B cell function: proliferation, cyclic AMP generation, Ig production, and B-cell receptor expression. J. Allergy Clin. Immunol. 105 (2000) 975-982
40. Pham C.G., Bubici C., Zazzeroni F., Papa S., Jones J., Alvarez K., Jayawardena S., De Smaele E., Cong R., Beaumont C., et al. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 119 (2004) 529-542
41. Qiao X., He B., Chiu A., Knowles D.M., Chadburn A., and Cerutti A. Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nat. Immunol. 7 (2006) 302-310
42. Rautonen J., Rautonen N., Martin N.L., Philip R., and Wara D.W. Serum interleukin-6 concentrations are elevated and associated with elevated tumor necrosis factor-alpha and immunoglobulin G and A concentrations in children with HIV infection. AIDS 5 (1991) 1319-1325
43. Shirai A., Cosentino M., Leitman-Klinman S.F., and Klinman D.M. Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation. J. Clin. Invest. 89 (1992) 561-566
44. Swingler S., Mann A., Jacque J., Brichacek B., Sasseville V.G., Williams K., Lackner A.A., Janoff E.N., Wang R., and Fisher D. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat. Med. 5 (1999) 997-1103
45. Swingler S., Brichacek B., Jacque J.M., Ulich C., Zhou J., and Stevenson M. HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection. Nature 424 (2003) 213-219
46. Yoshioka M., Shapshak P., Sun N.C., Nelson S.J., Svenningsson A., Tate L.G., Pardo V., and Resnick L. Simultaneous detection of ferritin and HIV-1 in reactive microglia. Acta Neuropathol. (Berl.) 84 (1992) 297-306
47. Yuan X., Cong Y., Hao J., Shan Y., Zhao Z., Wang S., and Chen J. Regulation of LIP level and ROS formation through interaction of H-ferritin with G-CSF receptor. J. Mol. Biol. 339 (2004) 131-144